Correspondence 0001104659-24-010625 from STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194) (LAB)
STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)
Date: Feb. 5, 2024 · CIK: 0001162194 · Accession: 0001104659-24-010625
AI Filing Summary & Sentiment
File numbers found in text: 333-276628
Letter
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
February 5, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Robert Augustin
RE: Standard BioTools Inc.
Registration Statement on Form S-3, as amended
File No. 333-276628
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-3, as amended (File No. 333-276628) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Time on Wednesday, February 7, 2024, or as soon as possible thereafter.
The Company hereby authorizes John T. Rudy, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Mr. Rudy at (617) 348-3050 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Mr. Rudy.
Very truly yours,
Standard biotools INC.
Show Raw Text
CORRESP
1
filename1.htm
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
February 5, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Robert Augustin
RE: Standard BioTools Inc.
Registration Statement on Form S-3, as amended
File No. 333-276628
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461
promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests
acceleration of the effective date of the Registration Statement on Form S-3, as amended (File No. 333-276628) (the “Registration
Statement”), so that it may become effective at 4:00 p.m. Eastern Time on Wednesday, February 7, 2024, or as soon
as possible thereafter.
The Company hereby authorizes
John T. Rudy, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests
that it be notified of such effectiveness by a telephone call to Mr. Rudy at (617) 348-3050 and that such effectiveness also be confirmed
in writing. Any questions regarding this request may be addressed to Mr. Rudy.
Very truly yours,
Standard biotools INC.
/s/
Jeffrey Black
Jeffrey Black
Chief Financial Officer
cc:
Standard BioTools Inc.
Michael Egholm, Ph.D., President and Chief Executive Officer
Agnieszka Gallagher, Esq., Senior Vice President and
Chief Legal Officer
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
John T. Rudy, Esq.